SEC Form 4 · accession 0001618835-18-000084
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell Barrans
Officer — Chief Commercial Officer
Period of report
Aug 10, 2018
Accepted (ET)
Aug 13, 2018 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2018 | P | 3,715 | $1.98 | A | 12,541 | D |
Table II — derivative securities
No Table II lines on this filing.